Table 1.
Table summarizing reported cases of urachal inflammatory myofibroblastic tumor
| Age | Sex | Symptoms | Tumor location to bladder | Tumor size(largest diameter in cm) | Surgery | IHC | Molecular studies | |
|---|---|---|---|---|---|---|---|---|
| Wang K et al.3 | 77 | F | LAM | Suprapubic mass with central necrosis and hemorrhage | 10 | Excision with partial cystectomy | SMA-1+ Vimentin 3+ ALK1 -, |
Not done |
| Nascimento AF et al.4 | 10 | M | LAP | Superior and anterior cystic mass | 3.5 | excision with resection of dome of bladder | ALK + SMA+ | Alk gene rearrangement by FISH positive |
| George R et al.5 | 27 | F | LAP and Dysuria | Peripherally enhancing solid and cystic mass superior and anterior | 3.2 | Excision with partial cystectomy | SMA(tramtrack), ALK+, | Alk gene rearrangement by FISH positive |
| Venkatesh K et al.6 | 50 | M | Dysuria and hematuria | Nodular anterosuperior mass extending to umbilicus | 3.8 | Excision with partial cystectomy | ALK +, SMA+ | Not done |
| Cerier E et al.7 | 41 | M | N, V, C,WL | Anterosuperior to bladder invading abdominal wall | 6.9 | Excision with partial cystectomy | SMA-1+, Desmin+, ALK1- |
Not done |
| Karibe J et al.8 | 25 | M | LAP and dysuria | Anterosuperior cystic mass with hemorrhage | 8 | Excision | ALK+, SMA+,Desmin+ | Not done |
| Wu Y et al.9 | 52 | F | LAM | NA | NA | NA | NA | NA |
| Tunca F et al.10 | 16 | M | LAP, hematuria, dysuria, | NA | 10 | Excision | SMA- | Not done |
| Kumar, Santosh et al.11 | 19 | M | Hematuria | Dome and anterior wall | 6 | Excision with partial cystectomy | NA | Not done |
| Sharma RK et al.12 | 12 | M | LAP, LAM | Anterosuperiorly pedunculated mass involving anterior abdominal wall | 11 | Excision | NA | Not done |
Abbreviations: LAP lower abdominal pain, LAM lower abdominal mass, N Nausea, V vomiting, WL weight loss, C constipation, NA not available.